Evidence map›Paper›PMID 41545701›Full record

ArticleLeukemia2026

Characteristics and prognostic significance of myelodysplasia-related features in VEXAS syndrome.

Lin-Pierre Zhao, Olivier Kosmider, Maël Heiblig, Thomas Moulinet, Valentin Lacombe, Thibault Comont, Hervé Lobbes, Jean-Denis Karam, Louis Terriou, Samuel Ardois and 17 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Myelodysplasia in VEXAS syndrome.Blood advances · 2026
    Review
  2. SomaticBlood neoplasia · 2026
    Article
  3. VEXAS syndrome.Nature reviews. Disease primers · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Lin-Pierre ZhaoHématologie Seniors, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France. linpierre.zhao@aphp.fr.ORCID http://orcid.org/0000-0001-5035-4470
Olivier KosmiderLaboratoire d'Hématologie, Hôpital Cochin, AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-6021-4057
Maël HeibligHématologie clinique, Hôpital Lyon Sud, Hospices Civils de Lyon (HCL), Pierre-Bénite, Lyon, France.
Thomas MoulinetMédecine Interne et Immunologie Clinique, CHU de Nancy, Université de Lorraine, Nancy, France.
Valentin LacombeMédecine interne et polyvalente, CH du Haut-Anjou, Château-Gontier, France.
Thibault ComontMédecine Interne, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT-Oncopole), CHU de Toulouse, Université Paul Sabatier, Toulouse, France.
Hervé LobbesMédecine Interne, CHU Estaing, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0002-8511-8432
Jean-Denis KaramMédecine Interne, CHU Amiens, Amiens, France.
Louis TerriouMédecine Interne et Immunologie Clinique, CHU de Lille, Université de Lille, Lille, France.
Samuel ArdoisMédecine Interne, CHU de Rennes, Rennes, France.
Guillaume Le GuennoMédecine Interne, CHU Estaing, Clermont-Ferrand, France.
Vincent JachietMédecine Interne, Hôpital Saint-Antoine, AP-HP, Paris, France.
Louis WolffMédecine Interne, Hôpital Erasme, Cliniques Universitaires de Bruxelles, Université Libre de Bruxelles, Bruxelles, Belgique.
Gaëlle VertenoeilHématologie clinique, Hôpital de Liège, Liège, Belgique.ORCID http://orcid.org/0000-0003-4129-882X
Jérôme HadjadjMédecine Interne, Hôpital Saint-Antoine, AP-HP, Paris, France.
Jean-David BouazizDermatologie, Hôpital Saint-Louis, AP-HP, Paris, France.
Pierre LemaireLaboratoire d'Hématologie, Hôpital Saint-Louis, AP-HP, Paris, France.
Olivier FainMédecine Interne, Hôpital Saint-Antoine, AP-HP, Paris, France.
Benjamin TerrierMédecine Interne, Hôpital Cochin, AP-HP, Paris, France.
Sophie Georgin-LavialleMédecine Interne, Hôpital Tenon, Sorbonne Université, AP-HP, Paris, France.
Lise LarcherUniversité Paris Cité, INSERM UMR 1342, Institut de Recherche Saint-Louis, Paris, France.ORCID http://orcid.org/0000-0002-9461-0728
Emmanuelle ClappierUniversité Paris Cité, INSERM UMR 1342, Institut de Recherche Saint-Louis, Paris, France.
Marie SébertHématologie Seniors, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0003-4376-4097
Lionel AdèsHématologie Seniors, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-9020-8766
Arsène MekinianMédecine Interne, Hôpital Saint-Antoine, AP-HP, Paris, France.ORCID http://orcid.org/0000-0003-2849-3049
Pierre FenauxHématologie Seniors, Assistance Publique - Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.
FRENVEX group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41545701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.